Skip to main content
Clinical Trials/NCT03540641
NCT03540641
Completed
Not Applicable

Effect of the Transcranial Magnetic Stimulation Applied on the Left Dorsolateral Prefrontal Cortex on the Clinical and Neuropsychological Variables in Subjects With Binge Eating Disorder

Universidad Autonoma de Queretaro1 site in 1 country30 target enrollmentApril 6, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Binge-Eating Disorder
Sponsor
Universidad Autonoma de Queretaro
Enrollment
30
Locations
1
Primary Endpoint
Food Craving Inventory (FCI)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This study evaluates de efficacy of 5Hz repetitive Transcranial Magnetic Stimulation (rTMS) applied on the left dorsolateral prefrontal cortex in patients with binge eating disorder.

Detailed Description

Binge Eating Disorder (BED) affects a significant percentage of de national population (1.4%) in a portio 2-1 in woman compared with men, the repetitive Transcranial Magnetic Stimulation (rTMS) is a neuromodulation technique, which allows us to induce brain electrical activity by plating magnetic fields and it has been proven that at 10Hz it has an effect of improvement in the craving of food.

Registry
clinicaltrials.gov
Start Date
April 6, 2017
End Date
December 30, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. Julian Reyes López

professor

Universidad Autonoma de Queretaro

Eligibility Criteria

Inclusion Criteria

  • Subjects of both sexes.
  • Subjects from 18 to 45 years of age.
  • Subjects with diagnosis of binge eating disorder.
  • Subjects without changes in pharmacological treatment in the last 30 days.
  • Subjects who agree to sign the informed consent letter.

Exclusion Criteria

  • 1.Subjects with a history of traumatic brain injury with loss of consciousness. 2.Subjects with intracranial metallic objects or metal plates in the skull.
  • 3.Subjects who suffer chronic diseases not controlled at the time of entering the study (for example: hypertension, diabetes, rheumatic diseases).
  • 4.Patients with psychotic symptoms, bipolar affective disorders and substance dependence.
  • 5.Subjects with alterations in electroencephalogram (epileptiform activity). 6.Patients with any type of chronic or neurological medical disease not controlled.

Outcomes

Primary Outcomes

Food Craving Inventory (FCI)

Time Frame: 6 weeks

The FCI is a self-report inventory designed to measure the food craving, is made up of 37 elements and is a scale-likert instrument.

Secondary Outcomes

  • Barratt Impulsivity Scale (BIS-11)(6 weeks)

Study Sites (1)

Loading locations...

Similar Trials